tradingkey.logo

Twist Bioscience Corp

TWST
48.293USD
-0.947-1.92%
交易中 美东报价延迟15分钟
1.29B总市值
亏损市盈率 TTM

Twist Bioscience Corp

48.293
-0.947-1.92%

关于 Twist Bioscience Corp 公司

Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that specializes in manufacturing synthetic DNA by writing DNA on a silicon chip. It has applied its technology to manufacture a range of synthetic DNA-based products, including synthetic genes, tools for next generation sequencing (NGS) sample preparation, and antibody libraries for drug discovery and development, all designed to enable its customers to conduct research. Its gene products include multiplexed gene fragments, express genes, clonal genes and gene fragments. The Company also manufactures synthetic ribonucleic acid (RNA) as well as antibody proteins. The Company's synthetic DNA tools are used in fields, such as medicine, agriculture, industrial chemicals and defense. It has minority ownership in Atlas Data Storage, Inc.

Twist Bioscience Corp简介

公司代码TWST
公司名称Twist Bioscience Corp
上市日期Oct 31, 2018
CEOLeproust (Emily M)
员工数量979
证券类型Ordinary Share
年结日Oct 31
公司地址681 Gateway Blvd.
城市SOUTH SAN FRANCISCO
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编94080
电话18007190671
网址https://www.twistbioscience.com/
公司代码TWST
上市日期Oct 31, 2018
CEOLeproust (Emily M)

Twist Bioscience Corp公司高管

名称
名称/职务
职务
持股
持股变动
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
414.69K
-5001.00%
Mr. Patrick John Finn, Ph.D.
Mr. Patrick John Finn, Ph.D.
President, Chief Operating Officer
President, Chief Operating Officer
98.66K
-2705.00%
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
94.05K
+1343.00%
Ms. Paula Green
Ms. Paula Green
Senior Vice President - Human Resources
Senior Vice President - Human Resources
69.29K
-1194.00%
Mr. Dennis Cho
Mr. Dennis Cho
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
60.72K
-1099.00%
Mr. Adam Laponis
Mr. Adam Laponis
Chief Financial Officer
Chief Financial Officer
31.82K
-5738.00%
Mr. Nelson C. Chan
Mr. Nelson C. Chan
Independent Director
Independent Director
23.68K
+1436.00%
Dr. Melissa A. Starovasnik, Ph.D.
Dr. Melissa A. Starovasnik, Ph.D.
Independent Director
Independent Director
17.16K
+1344.00%
Mr. Jan Johannessen
Mr. Jan Johannessen
Independent Director
Independent Director
10.39K
+4834.00%
Mr. Robert B. (Rob) Chess
Mr. Robert B. (Rob) Chess
Lead Independent Director
Lead Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
414.69K
-5001.00%
Mr. Patrick John Finn, Ph.D.
Mr. Patrick John Finn, Ph.D.
President, Chief Operating Officer
President, Chief Operating Officer
98.66K
-2705.00%
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
94.05K
+1343.00%
Ms. Paula Green
Ms. Paula Green
Senior Vice President - Human Resources
Senior Vice President - Human Resources
69.29K
-1194.00%
Mr. Dennis Cho
Mr. Dennis Cho
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
60.72K
-1099.00%
Mr. Adam Laponis
Mr. Adam Laponis
Chief Financial Officer
Chief Financial Officer
31.82K
-5738.00%

收入明细

单位: USD更新时间: 1月6日 周二
单位: USD更新时间: 1月6日 周二
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
NGS tools
208.10M
55.26%
Synthetic genes
113.60M
30.17%
Antibody discovery
23.45M
6.23%
Oligo pools
20.23M
5.37%
DNA libraries
11.18M
2.97%
地区USD
名称
营收
占比
Americas
225.58M
59.90%
EMEA
124.24M
32.99%
APAC
26.75M
7.10%
业务
地区
业务USD
名称
营收
占比
NGS tools
208.10M
55.26%
Synthetic genes
113.60M
30.17%
Antibody discovery
23.45M
6.23%
Oligo pools
20.23M
5.37%
DNA libraries
11.18M
2.97%

股东统计

更新时间: 11月16日 周日
更新时间: 11月16日 周日
持股股东
股东类型
持股股东
持股股东
占比
ARK Investment Management LLC
12.33%
Artisan Partners Limited Partnership
9.51%
The Vanguard Group, Inc.
9.40%
BlackRock Institutional Trust Company, N.A.
7.85%
William Blair Investment Management, LLC
6.76%
其他
54.16%
持股股东
持股股东
占比
ARK Investment Management LLC
12.33%
Artisan Partners Limited Partnership
9.51%
The Vanguard Group, Inc.
9.40%
BlackRock Institutional Trust Company, N.A.
7.85%
William Blair Investment Management, LLC
6.76%
其他
54.16%
股东类型
持股股东
占比
Investment Advisor
66.28%
Investment Advisor/Hedge Fund
36.10%
Hedge Fund
9.90%
Research Firm
5.44%
Pension Fund
1.58%
Individual Investor
1.58%
Bank and Trust
0.83%
Family Office
0.17%
Insurance Company
0.07%

机构持股

更新时间: 1月1日 周四
更新时间: 1月1日 周四
报告期
机构数
持股数
持股占比
持股变动
2025Q4
585
73.72M
120.24%
-3.30M
2025Q3
566
71.88M
119.09%
+752.75K
2025Q2
575
70.44M
116.72%
-302.44K
2025Q1
585
70.23M
117.22%
-1.63M
2024Q4
578
67.47M
113.11%
-8.03M
2024Q3
588
67.80M
115.74%
-8.48M
2024Q2
579
66.59M
114.39%
-10.53M
2024Q1
565
68.18M
117.94%
-8.61M
2023Q4
559
67.81M
117.39%
-11.70M
2023Q3
560
68.09M
118.66%
-11.36M
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
ARK Investment Management LLC
6.73M
10.98%
+326.37K
+5.10%
Sep 30, 2025
Artisan Partners Limited Partnership
6.41M
10.46%
+1.35M
+26.67%
Sep 30, 2025
The Vanguard Group, Inc.
5.76M
9.39%
-63.16K
-1.09%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
4.81M
7.85%
-46.27K
-0.95%
Sep 30, 2025
William Blair Investment Management, LLC
4.14M
6.76%
+235.68K
+6.03%
Sep 30, 2025
EdgePoint Investment Group Inc.
4.08M
6.66%
+1.70M
+71.10%
Sep 30, 2025
State Street Investment Management (US)
3.09M
5.04%
+588.07K
+23.51%
Sep 30, 2025
Amova Asset Management Co., Ltd.
2.12M
3.46%
-179.23K
-7.79%
Sep 30, 2025
Soleus Capital Management, L.P.
1.87M
3.05%
+1.51M
+426.59%
Sep 30, 2025
Millennium Management LLC
1.79M
2.93%
+1.08M
+151.55%
Sep 30, 2025
查看更多

持股ETF

更新时间: 12月2日 周二
更新时间: 12月2日 周二
机构名称
占比
ARK Genomic Revolution ETF
6.24%
iShares Genomics Immunology and Healthcare ETF
3.92%
Global X Genomics & Biotechnology ETF
2.09%
ROBO Global Healthcare Technology & Innovation ETF
2%
WisdomTree BioRevolution Fund
1.79%
ARK Innovation ETF
1.47%
Franklin Genomic Advancements ETF
1.17%
State Street SPDR S&P Biotech ETF
0.92%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.66%
Direxion Daily S&P Biotech Bull 3X Shares
0.56%
查看更多
ARK Genomic Revolution ETF
占比6.24%
iShares Genomics Immunology and Healthcare ETF
占比3.92%
Global X Genomics & Biotechnology ETF
占比2.09%
ROBO Global Healthcare Technology & Innovation ETF
占比2%
WisdomTree BioRevolution Fund
占比1.79%
ARK Innovation ETF
占比1.47%
Franklin Genomic Advancements ETF
占比1.17%
State Street SPDR S&P Biotech ETF
占比0.92%
First Trust Nasdaq Lux Digi Health Solutions ETF
占比0.66%
Direxion Daily S&P Biotech Bull 3X Shares
占比0.56%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
KeyAI